4//SEC Filing
Dachille Douglas A. 4
Accession 0000899243-22-011246
CIK 0001743881other
Filed
Mar 15, 8:00 PM ET
Accepted
Mar 16, 4:46 PM ET
Size
5.6 KB
Accession
0000899243-22-011246
Insider Transaction Report
Form 4
Dachille Douglas A.
Director
Transactions
- Purchase
Common Stock
2022-03-14$8.19/sh+10,000$81,934→ 20,000 total(indirect: By Trust)
Footnotes (2)
- [F1]Represents the weighted average purchase price of the shares purchased from $8.1699 to $8.2084 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased at each separate price for all transactions as reported in this footnote.
- [F2]These shares are owned directly by The Dachille 2012-1 Family Trust for the benefit of the reporting person's children, for which the reporting person's spouse is the trustee. The reporting person disclaims Section 16 beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 or any other purpose.
Documents
Issuer
BridgeBio Pharma, Inc.
CIK 0001743881
Entity typeother
Related Parties
1- filerCIK 0001652908
Filing Metadata
- Form type
- 4
- Filed
- Mar 15, 8:00 PM ET
- Accepted
- Mar 16, 4:46 PM ET
- Size
- 5.6 KB